These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1333691)

  • 1. Antigens involved in vaccination of swine against Aujeszky's disease (pseudorabies) virus.
    Eiras A; Puentes E; Seoane R; Cancio E; Nores MV; Regueiro BJ
    Zentralbl Veterinarmed B; 1992 Sep; 39(7):526-36. PubMed ID: 1333691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the protective efficacy of Aujeszky's disease (pseudorabies) virus glycoproteins obtained from different sources.
    Puentes E; Eiras A; Cancio E; Nores MV; Aguilera A; Seoane R; Regueiro BJ
    Vet Microbiol; 1993 May; 35(1-2):45-59. PubMed ID: 8395745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine.
    Mukamoto M; Watanabe I; Kobayashi Y; Icatlo FC; Ishii H; Kodama Y
    Vet Microbiol; 1991 Oct; 29(2):109-21. PubMed ID: 1660638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of different vaccination schedules for sows to protect piglets against Aujeszky's disease.
    Casal J; Planasdemunt L; Varo JA; Martín M
    J Vet Med B Infect Dis Vet Public Health; 2004 Feb; 51(1):8-11. PubMed ID: 14995971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination of piglets of different ages with inactivated Aujeszky's disease vaccine].
    Jakubik J; Wittmann G
    Berl Munch Tierarztl Wochenschr; 1979 Sep; 92(17):343-5. PubMed ID: 231429
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of pigs against Aujeszky's disease by DNA vaccination.
    Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against Aujeszky's disease: comparison of efficacy, DNA fingerprints and antibody response to glycoprotein I.
    van Oirschot JT; Gielkens AL
    Vet Q; 1987 Nov; 9 Suppl 1():37S-49S. PubMed ID: 2829410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
    Hopp W; Jungblut R
    Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of a lectin-agarose based subunit vaccine and complementary diagnostic antigen for Aujeszky's disease (pseudorabies) in the pig.
    Platt KB
    Vet Microbiol; 1984 Feb; 9(1):35-51. PubMed ID: 6326377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of vaccination route on the efficacy of Aujeszky's disease deletion-mutant vaccine.
    Hasebe H; Osorio FA; Hogg A; Liauw H; Bartkoski MJ; Sugiyama M
    J Vet Med Sci; 1992 Aug; 54(4):693-8. PubMed ID: 1327180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous vaccination against Aujeszky's disease and European hog cholera].
    Bengelsdorff HJ; Becker W; Steinhoff H; Barth R
    Berl Munch Tierarztl Wochenschr; 1985 Apr; 98(4):109-12. PubMed ID: 2986592
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vaccination trial against Aujeszky's disease: development of antibody titers in sow serum, colostrum and the serum of suckling piglets and the influence of maternal antibodies on the serologic vaccination reaction of weaned piglets].
    Tenhagen BA; Bollwahn W; Seidler MJ
    Dtsch Tierarztl Wochenschr; 1995 Feb; 102(2):86-90. PubMed ID: 7600945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
    Mikulska-Skupień E; Szweda W; Procajło Z
    Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal vaccination of pigs against Aujeszky's disease. 4. Comparison with one or two doses of an inactivated vaccine in pigs with moderate maternal antibody titres.
    Van Oirschot JT; De Leeuw PW
    Vet Microbiol; 1985 Aug; 10(5):401-8. PubMed ID: 2996212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aujeszky's disease: serological responsiveness after vaccination of 6-10-week-old piglets with maternal antibody (author's transl)].
    Tielen MJ; van Exsel AC; Brus DH; Truijen WT
    Tijdschr Diergeneeskd; 1981 Aug; 106(15):739-47. PubMed ID: 6269250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral and intranasal vaccination of fattening pigs against Aujeszky's disease (pseudorabies).
    Pensaert M; Maes L
    Zentralbl Veterinarmed B; 1984 Oct; 31(9):682-9. PubMed ID: 6097071
    [No Abstract]   [Full Text] [Related]  

  • 20. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
    Gerdts V; Jöns A; Mettenleiter TC
    Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.